You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 272 No. 17, November 2, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Successful Pregnancy in Cystinosis

Peter A. Andrews, MRCP; Steven H. Sacks, FRCP
Guy's Hospital London, England

William van't Hoff, MRCP
Institute of Child Health London, England

JAMA. 1994;272(17):1327-1328.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Cystinosis is an autosomal recessive disorder in which accumulation of lysosomal cystine leads to renal failure, growth retardation, photophobia, endocrine dysfunction, and other late complications.1,2 In their article from the National Institutes of Health reviewing the adult manifestations of the disease,2 Dr Theodoropoulos and colleagues give details of endocrine manifestations but do not address the question of female fertility. We wish to report a successful pregnancy in a cystinotic woman who had received treatment with phosphocysteamine.

In 1965 when this patient was 27 months old, cystinosis was diagnosed following failure to thrive and a renal tubular Fanconi syndrome. Later complications included epilepsy, corneal crystals, hypertension, and hypothyroidism. Renal impairment developed, and she received a successful living related renal transplant in November 1975. In 1987, she started treatment with phosphocysteamine, cystine levels subsequently being maintained with administration of less than 1.5 nmol of half cystine per . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.